Post-transplant diabetes mellitus - Risk factors and effects on the function and morphology of the allograft

Acta Physiologica Hungarica

Volumn 99, Issue 2, 2012, Pages 206-215

  Borda, B ^a   Lengyel, C S ^a   Szederkenyi E ^a   Eller, J ^a   Keresztes, C S ^b   Lazar G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Immunosuppressive therapy; Post transplant diabetes mellitus; Protocol biopsy

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; EVEROLIMUS; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL ANTIDIABETIC AGENT; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; POSTTRANSPLANT DIABETES MELLITUS; RISK FACTOR;

ADULT; BIOPSY; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; HUMANS; HUNGARY; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864686845     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.99.2012.2.14     Document Type: Article

References (31)

1. American Diabetes Association: Diagnosis and classifi cation of diabetes mellitus. Diabetes Care 33, Suppl. 1 (2010)
2. Arif M, Arif MK, Arif MS: An evoluation of renal biopsy in type-II diabetic patients. J. Cole Physicians Surg. Pak. 19, 627-631 (2009)
3. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K: DECODE Study Group; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia 47, 2118-2128 (2004) (Pubitemid 40174684)
4. Borda B, Szederkényi E, Lengyel C, Morvay Z, Eller J, Marofka F, Szabó V, Takács T, Szenohradszky P, Hódi Z, Lázár Gy: Functional and histopathological changes in renal transplant patients with new-onset diabetes and dyslipidemia. Transplant. Proc. 43, 1254-1258 (2011)
5. Ciancio G, Burke GW, Gaynor JJ, Ruiz P, Roth D, Kupin W, Rosen A, Miller J: A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporin/sirolimus in renal transplantation: three-year analysis. Transplantation 81, 845-852 (2006)
6. Cosio FG, Kudva Y, Veldel M, Larson ST, Textor CS, Griffin DM, Stegall DM: New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 67, 2415-2421 (2005) (Pubitemid 41623405)
7. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC: New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation. 75 (Suppl. 10), SS3-SS24 (2003)
8. Fresnedo GF, Plumed JS, Arias M, Caba DC, Oliva MO: Progression factors in chronic kidney disease. Nonimmunological mechanisms. Nefrologia 29 (Suppl. 1), 16-24 (2009)
9. Gallon LG, Winoto J, Leventhal RJ, Parker AM, Kaufman BDl: Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin. J. Am. Soc. Nephrol. 1, 907-908 (2006)
10. Heisel O, Heisel R, Balshaw R, Keown P: New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am. J. Transplant. 4, 583-595 (2004) (Pubitemid 38523581)
11. Helanterä I, Ortiz F, Räisänen-Sokolowski A, Koskinen P: Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies. Transpl. Int. 4, 374-381 (2010)
12. Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrançois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY: Diabetes mellitus after kidney transplantation a French multicentre observational study. Nephrol. Dial. Transplant. 22, 1986-1993 (2007) (Pubitemid 47244771)
13. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am. J. Transplant. 3, 178-185 (2003) (Pubitemid 36323115)
14. Kasiske BL, Chakkera AH, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J. Am. Soc. Nephrol. 11, 1735-1743 (2000)
15. Lee YJ, Kim B, Lee JE, Kim YG, Kim DJ, Kim SJ, Joh JW, Oh HY, Huh W: Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up. Transplant. Int. (Sep. 9) (2009)
16. Li C, Yang CW: The pathogenesis and treatment of chronic allograft nephropathy. Nat. Rev. Nephrol. 5, 513-519 (2009)
17. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 25, 583-592 (2002)
18. Moreau K: Post-transplantation diabetes mellitus. Nephrol. Ther. (Suppl. 1) S71-S76 (2006) (Pubitemid 43156012)
19. Ossareh S, Naseem S, Faraji MA, Bahrami Asl M, Yousefnejad A: Frequency and risk factors for posttransplant diabetes mellitus in Irianian renal transplant patients. Transplant. Proc. 41, 2814-2816 (2009)
20. Pascual J, Quereda C, Zamora J, Hernández D: Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantion 78, 1548-1556 (2004) (Pubitemid 39552943)
21. Racusen LC, Halloran FP, Solez K: Banff 2003 meeting report: new diagnostic insights and standards. Am. J. Transplant. 4, 1562-1566 (2004) (Pubitemid 39312289)
22. Schiel R, Heinrich S, Steiner T, Ott U, Stein G: Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis. Clin. Exp. Nephrol. 9, 164-169 (2005) (Pubitemid 40875108)
23. Seifi S, Rahbar M, Lessan-Pezeshki M, Khatami MR, Abbasi MR, Mahdavi-Mazdeh M, Ahmadi F, Maziar S: Posttransplant diabetes mellitus incidence and risk factors. Transplant. Proc. 41, 2811-2813 (2009)
24. Shah T et al.: Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 82, 1673-1676 (2006) (Pubitemid 46035650)
25. Sharma A, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, Bunnapradist S: Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression. Transplant. Proc. 40, 2414-2415 (2008)
26. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN'). Am. J. Transplant. 7, 518 (2007)
27. Türk T, Pietruck F, Dolff S, Kribben A, Janssen OE, Mann K, Philipp T, Heemann U, Witzke O: Repeglinide in the management of new-onset diabetes mellitus after renal transplantation. Am. J. Transplant. 6, 842-846 (2006) (Pubitemid 43345023)
28. Valderhang TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J: Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88, 429-434 (2009)
29. Van Duijnhoven EM, Boots JM, Christiaans MH, van Hooff JP: Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus. Minerva Urol. Nefrol. 55, 33-42 (2003) (Pubitemid 36799016)
30. Veroux M, Coronaa D, Giuffridaa G, Gaglianoa M, Sorbellob M, Virgilioa C, Tallaritaa T, Zerboa D, Giaquintaa A, Fiamingoa P, Macaronea M, Li Voltia G, Cagliaa B, Veroux P: New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression. Transplant. Proc. 40, 1885-1887 (2008)
31. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N: Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 7, 1-9 (2007)